Plasma Phospholipids and Fatty Acid Composition Differ Between Liver Biopsy-Proven Nonalcoholic Fatty Liver Disease and Healthy Subjects

Nutrition and Diabetes - United Kingdom
doi 10.1038/nutd.2016.27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Plasma Levels of Asymmetric Dimethylarginine in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2011English

Nonalcoholic Fatty Liver Disease

Hypertension
Internal Medicine
2020English

Nonalcoholic Fatty Liver Disease

Gastroenterology
HepatologyGastroenterology
2002English

Ethnicity and Nonalcoholic Fatty Liver Disease

Hepatology
MedicineHepatology
2012English

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis

Journal of Clinical and Experimental Hepatology
Hepatology
2015English

Nonalcoholic Fatty Liver Disease and Colorectal Neoplasia

Gastroenterology
HepatologyGastroenterology
2017English

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Nonalcoholic Fatty Liver Disease in Psoriasis

British Journal of Dermatology
DermatologyMedicine
2018English

The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Comorbidities

Hepatology
MedicineHepatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy